Insulet Corp.

{
  "main_header": {
    "sid": 1156053,
    "name": "Insulet Corp.",
    "stock_name": "Insulet Corp.",
    "full_name": "Insulet Corp.",
    "name_url": "stocks-analysis/insulet-corp",
    "exchange": 210,
    "exchangecode": "NAS",
    "country_id": 2,
    "currency": "USD",
    "cmp": "271.60",
    "chg": -8.4,
    "chgp": "-3.0%",
    "dir": -1,
    "prev_price": "280.00",
    "mcapval": "20,059.06",
    "mcap": "Mid Cap",
    "scripcode": "",
    "symbol": "",
    "ind_name": "Pharmaceuticals & Biotechnology",
    "ind_code": 2325,
    "indexname": "S&P 500",
    "isin": "US45784P1012",
    "curr_date": "Jan 23",
    "curr_time": "",
    "bse_nse_vol": "1.07 M",
    "exc_status": "Active",
    "traded_date": "Jan 23, 2026",
    "traded_date_str": "2026 01 23",
    "score": "",
    "scoreText": "",
    "Live": 0,
    "market_time": 0,
    "is_blur": 1,
    "is_blur_class": "blur-registerF-score-header",
    "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/insulet-corp-1156053-210&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0
    }
  },
  "news": {
    "results": [
      {
        "title": "Insulet Corp. Experiences Evaluation Revision Amid Strong Market Performance and Technical Indicators",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/insulet-corps-technical-trend-shifts-from-bullish-to-mildly-bullish-amid-mixed-signals-3652025",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/10/InsuletCorp_technicaldot_3652025.png",
        "date": "2025-10-28 15:22:08",
        "description": "Insulet Corp., a midcap in the Pharmaceuticals & Biotechnology sector, has shown strong performance with a 37.10% return over the past year, significantly outperforming the S&P 500. Current stock price is $325.80, reflecting recent market evaluations amid mixed technical indicators and a notable trading range."
      },
      {
        "title": "Is Insulet Corp. technically bullish or bearish?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/is-insulet-corp-technically-bullish-or-bearish-3651453",
        "imagepath": "",
        "date": "2025-10-28 11:43:39",
        "description": "As of 24 October 2025, the technical trend for Insulet Corp. has changed from bullish to mildly bullish. The current stance is mildly bullish, supported by daily moving averages and a bullish indication from Bollinger Bands on both weekly and monthly time frames. However, the weekly MACD and KST are mildly bearish, and the monthly RSI is bearish, indicating mixed signals. \n\nIn terms of performance, Insulet has outperformed the S&P 500 year-to-date with a return of 22.92% compared to the S&P 500's 15.47%, and over the past year, it has returned 35.05% versus the S&P 500's 16.90%. However, over the longer term, it has underperformed the S&P 500 significantly in the 3-year, 5-year, and 10-year periods...."
      },
      {
        "title": "Is Insulet Corp. technically bullish or bearish?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/is-insulet-corp-technically-bullish-or-bearish-3647907",
        "imagepath": "",
        "date": "2025-10-27 11:54:47",
        "description": "As of 24 October 2025, the technical trend for Insulet Corp. has changed from bullish to mildly bullish. The current stance is mildly bullish, supported by daily moving averages and a bullish indication from Bollinger Bands. However, the weekly MACD and KST are mildly bearish, and the monthly RSI is bearish, indicating some mixed signals. \n\nIn terms of performance, Insulet has outperformed the S&P 500 year-to-date with a return of 22.92% compared to the S&P's 15.47%, and over the past year, it has returned 35.05% versus the S&P's 16.90%. However, over the longer three-year and five-year periods, Insulet has significantly underperformed the S&P 500...."
      }
    ],
    "total": 14,
    "sid": "1156053",
    "stock_news_url": "https://www.marketsmojo.com/news/insulet-corp-1156053"
  },
  "announcements": "",
  "corporate_actions": {
    "msg": "No corporate action Found"
  }
}

News and Views

Insulet Corp. Experiences Evaluation Revision Amid Strong Market Performance and Technical Indicators

2025-10-28 15:22:08

Insulet Corp., a midcap in the Pharmaceuticals & Biotechnology sector, has shown strong performance with a 37.10% return over the past year, significantly outperforming the S&P 500. Current stock price is $325.80, reflecting recent market evaluations amid mixed technical indicators and a notable trading range.

Read full news article

Is Insulet Corp. technically bullish or bearish?

2025-10-28 11:43:39

As of 24 October 2025, the technical trend for Insulet Corp. has changed from bullish to mildly bullish. The current stance is mildly bullish, supported by daily moving averages and a bullish indication from Bollinger Bands on both weekly and monthly time frames. However, the weekly MACD and KST are mildly bearish, and the monthly RSI is bearish, indicating mixed signals. In terms of performance, Insulet has outperformed the S&P 500 year-to-date with a return of 22.92% compared to the S&P 500's 15.47%, and over the past year, it has returned 35.05% versus the S&P 500's 16.90%. However, over the longer term, it has underperformed the S&P 500 significantly in the 3-year, 5-year, and 10-year periods....

Read full news article

Is Insulet Corp. technically bullish or bearish?

2025-10-27 11:54:47

As of 24 October 2025, the technical trend for Insulet Corp. has changed from bullish to mildly bullish. The current stance is mildly bullish, supported by daily moving averages and a bullish indication from Bollinger Bands. However, the weekly MACD and KST are mildly bearish, and the monthly RSI is bearish, indicating some mixed signals. In terms of performance, Insulet has outperformed the S&P 500 year-to-date with a return of 22.92% compared to the S&P's 15.47%, and over the past year, it has returned 35.05% versus the S&P's 16.90%. However, over the longer three-year and five-year periods, Insulet has significantly underperformed the S&P 500....

Read full news article

View All News